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Magnetic resonance (MR) colonography
in the detection of colorectal lesions:
a systematic review of prospective studies
Abstract Objective: To determine
the diagnostic accuracy of MR-colo-
nography for the detection of
colorectal lesions. Methods: A
comprehensive literature search was
performed for comparative MR-colo-
nography studies, published between
May 1997 and February 2009, using
the MEDLINE, EMBASE and Co-
chrane databases. We included studies
if MR-colonography findings were
prospectively compared with conven-
tional colonoscopy in (a)symptomatic
patients. Two reviewers indepen-
dently extracted study design charac-
teristics and data for summarising
sensitivity and specificity. Heteroge-
neity in findings between studies was
tested using I
2 test statistics. Sensi-
tivity and specificity estimates with
95% confidence intervals (CI) were
calculated on per patient basis and
summary sensitivity on per polyp
basis, using bivariate and univariate
statistical models. Results: Thirty-
seven studies were found to be
potentially relevant and 13 fulfilled
the inclusion criteria. The study pop-
ulation comprised 1,285 patients with
a mean disease prevalence of 44%
(range 22–63%). Sensitivity for the
detection of CRC was 100%. Signif-
icant heterogeneity was found for
overall per patient sensitivity and
specificity. For polyps with a size of
10 mm or larger, per patient sensitiv-
ity and specificity estimates were 88%
(95% CI 63–97%; I
2=37%) and 99%
(95% CI 95–100%; I
2=60%). On a
per polyp basis, polyps of 10 mm or
larger were detected with a sensitivity
of 84% (95% CI 66–94%; I
2=51%).
The data were too heterogeneous for
polyps smaller than 6 mm and 6–
9 mm. Conclusion: MR-colonogra-
phy can accurately detect colorectal
polyps more than 10 mm in size
Keywords Magnetic resonance
imaging (MRI) . Colorectal cancer
(CRC) . Colonic polyps . Systematic
review . Diagnostic accuracy
Introduction
Colonography comprises a complete colon examination that
canbeperformedwitheithercomputedtomography(CT)[1]
ormagneticresonanceimaging(MRI)[2].CT-colonography
has been reported to be a feasible, safe, well-tolerated
examination with good diagnostic accuracy for the detection
of colorectal polyps and cancer (CRC) [3]. Unfortunately,
CT-colonography requires ionising radiation, which poses a
substantial drawback to large-scale use in patients at both
average and increased risk of CRC [4]. Although some
studies have shown that substantial dose reduction in CT-
colonography is feasible [5, 6], an alternative imaging
method that does not require ionising radiation would be
preferable, especially for screening purposes.
Since 1997, several research groups have investigated
the use of MR-colonography. These studies show a large
variation in terms of bowel preparation used, luminal
contrast agents and imaging features. However in general,
two main strategies can be identified for the visualisation of
the colonic lumen and wall, i.e. the bright lumen and the
dark lumen strategy [2, 7].
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graphy, to date only one meta-analysis concerning an
overall estimation of the diagnostic accuracy of MR-
colonography for the diagnosis of colorectal masses has
been carried out [8]. However, in that meta-analysis limited
evaluation was performed regarding the detection of
different polyp size thresholds. Additionally, that meta-
analysis was performed in 2004 and mainly concerned
earlier studies, which were conducted in relatively small
population cohorts. Considering the quantity of studies
performed since 2004 and the rapid developments and
associated progress in the MRI field, an update seems
warranted.
Therefore the primary aim of this study was to perform a
systematic review and meta-analysis of the diagnostic
accuracy of MR-colonography compared with the refer-
ence standard (colonoscopy) for the detection of colorectal
lesions, with a special interest in different polyp size
thresholds. Our secondary aim was to assess the methodo-
logical quality and accuracy of reporting of the available
primary studies by using the QUADAS tool and thereby to
propose future reporting recommendations.
Materials and methods
Literature search
A computer-assisted literature search was performed of the
MEDLINE, EMBASE and Cochrane databases for relevant
publications on the accuracy of MR-colonography in
detecting colorectal lesions (see Appendix). We searched
the databases for publications dating from May 1997, when
MR-colonography was first described [2], to February
2009. There were no language restrictions. One observer
(FZ) assessed the title and/or abstract of all retrieved
papers to identify relevant articles for inclusion. Papers
were considered ineligible if from reading the title or
abstract it appeared that the paper was irrelevant, did
not meet all the inclusion criteria or met any of the
exclusion criteria. Reference lists of review articles and
papers selected for inclusion were checked by hand to
identify other relevant papers. The eligible articles were
retrieved as full-text articles and independently checked
by two reviewers (FZ,SB) for inclusion and exclusion
criteria.
Inclusion and exclusion criteria
Full prospective reports in which subjects at average or
increased risk of CRC underwent 1.5-T or 3.0-T MR-
colonography and completed colonoscopy for verification
were considered for inclusion. Furthermore eligible studies
needed to focus on the detection of colorectal polyps and
CRC, irrespective of histological findings. Inclusion
criteria also required the construction of 2×2 tables, either
by extracting true-positive (TP), false-negative (FN), false-
positive (FP) and true-negative (TN) values or by
reconstructing from sensitivity and specificity values.
Studies that reported any diagnosis other than colorec-
tal polyps and/or CRC or in which the accuracy of
detecting colorectal polyps could not be extrapolated from
the paper were excluded from our study. In addition
studies with less than 10 patients were excluded. If there
was any suspicion of a duplicate study, with a noticeable
overlap of the study population, the most recent study
with the largest population cohort was considered for
inclusion. Disagreement between the two reviewers
regarding inclusion and exclusion criteria was resolved
by consensus. If a primary study was considered for
inclusion but additional information was required because
of the incompleteness of the data sets, the corresponding
author was contacted.
Study characteristics
Methodological quality assessment and relevant data
extraction were independently performed by the same
two reviewers using a standardised form. In the event of
disagreement, a decision was made by consensus. No
blinding to the authors’ information, publication year or
journal title was applied.
Study quality assessment
To assess the methodological quality of the included
studies and to detect potential bias, ten relevant items (a–j)
of the Quality Assessment of Diagnostic Accuracy Studies
in Systematic Reviews (QUADAS) tool were used [9]. We
focused on the qualitative assessment of the included study
population, index test and reference test. Therefore we
assessed study population characteristics, such as number
of included subjects; definition of potential CRC risk
factors; whether subjects were consecutively recruited;
mean or median age with age range and sex distribution (a).
We determined whether a clear description of selection
criteria was reported (b) and whether an accurate reference
test (i.e. colonoscopy) was used (c). In addition, we
determined the possibility of a disease progression bias.
Therefore we documented the time interval between MR-
colonography and colonoscopy, assuming that the index
test always preceded the reference test (maximum time-
interval 4 weeks) (d). To exclude the possibility of a partial
verification bias, we assessed whether the whole sample
or a random selection of the sample received verification
by means ofcolonoscopy: we accepted asample of at least
90% receiving the reference test as complete verification
(e). Furthermore we recorded if a clear description was
given for the execution of the index test (f), if the index
1032test findings were interpreted without knowledge of the
reference standard (g), and if the reference standard was
potentially adjusted by the index test findings (e.g.
segmental unblinding, reassessment) (h). Additionally
we investigated whether intermediate test results were
reported in the included studies (i) and if withdrawals
were reported (j).
Imaging features
If available, the following characteristics were documented
regarding bowel preparation methods: (a) type of bowel
preparation; (b) in the case of limited bowel preparation
methods specification of contrast material used; (c) type of
dietary restrictions; (d) type of colonic luminal contrast
method applied; (e) amount of enema and pressure used if
recorded; (f) amount and type of spasmolytic drugs, if
administered. In addition we recorded the following MR
imaging characteristics: (g) magnetic field strength; (h)
intravenous paramagnetic contrast material used; (i) imag-
ing parameters (e.g. acquisition time and imaging plane);
(j) imaging procedure positions; and (k) total examination
time.
Imaging analysis
The following data regarding image analysis, data handling
and the reference standard were extracted from the selected
studies, if available: (a) image quality assessment (evalua-
tion regarding bowel distension, motion artefacts, lumen
homogeneity); (b) type of data interpretation (two-dimen-
sional reading (2D), three-dimensional reading (3D) or
both); (c) number of observers; (d) definition of observer
experience; (e) definition of consensus reading in the case
of multiple observers; (f) review time; and (g) histological
findings.
Data extraction
For each report, we attempted to construct a 2×2
contingency table, consisting of TP, FN, FP and TN values
for per patient analysis purposes. For the per patient
analysis, 2×2 tables were constructed for patients with any
polyp (irrespective of size) and patients with large polyps
(10 mm or larger).
For per polyp analyses TP and FN values were extracted
or reconstructed from each of the included studies. We
attempted to stratify the extracted data into three different
polyp size thresholds that are generally applied in
colonography literature, based on the associated potential
CRC risk [10]. Small polyps are generally defined as
polyps measuring less than 6 mm, medium polyps measure
between 6 and 9 mm, and large polyps have a size of
10 mm or larger. Additionally we attempted to extract
subset analysis of adenomas and CRC, if data were
available.
Data analysis
Per patient analysis
Per study we constructed 2×2 contingency tables for MR-
colonography compared with the reference standard and
calculated sensitivity as TP/(FN+TP) and specificity as
TN/(FP+TN). For the assessment of heterogeneity the I
2
test statistic was used. The I
2 test is a measure of
inconsistency describing the percentage of total variation
between studies that is due to heterogeneity, with larger
percentages indicating increasing heterogeneity [11]. In the
case of an I
2 value larger than 75%, we assumed that data
were significantly heterogeneous; consequently no data
pooling was performed.
In all other cases, I
2 values less than 75%, we used
the following bivariate statistical models to summarise
results for meta-analysis: the random effects model
(random for both sensitivity as well as specificity, both
I
2 values between 25% and 75%), the fixed effects
model (homogeneous for both sensitivity and specific-
ity, both I
2 values less than 25%) or the mixed effects
model (e.g. random for sensitivity and fixed for
specificity, one I
2 value less than 25% and the other
I
2 value between 25% and 50%).
The bivariate effects model [12]w a su s e dt o
summarise estimates of sensitivity and specificity with
95% confidence intervals. In this bivariate effects
model, the logit-transformed sensitivities and logit-
transformed specificities are assumed to follow a
bivariate normal distribution across studies around a
mean logit-sensitivity and mean logit-specificity, and
therefore mean logit-sensitivity and mean logit-specific-
ity with corresponding standard errors were obtained.
After antilogit transformation, summary estimates of
sensitivity and specificity with their 95% confidence
intervals (CIs) were obtained.
Per polyp analysis
For each threshold per study we calculated sensitivity as
TP/(FN+TP). The I
2 test statistics was used to quantify
heterogeneity for sensitivity in percentages. In the case of
an I
2 value larger than 75% no data pooling was performed.
In all other cases, we used either univariate random effects
(I
2 values between 25% and 75%) or univariate fixed
effects models (I
2 values less than 25%) to obtain summary
estimates of sensitivity for meta-analysis. All analyses
were executed using SAS software (SAS 9.2 procNlmixed,
SAS Institute, Cary, NC, USA).
1033Results
Search characteristics
We retrieved 353 articles on the initial search. After
screening based on title and abstract, 316 papers were
excluded from our study. Main considerations for rejection
were duplicate studies (identical studies in MEDLINE,
EMBASE and Cochrane databases), study design (e.g.
review, letters and comments) and non-related topic (e.g.
IBD, CT-colonography) (Fig. 1). Thirty-seven papers were
considered for inclusion and the full-text papers were
retrieved.
Study design characteristics
Thirteen studies met all predefined criteria and were
included in this study (Fig. 1). Study design characteristics
of all included studies are outlined in Table 1. Ten selected
studies [38–45, 48, 49] provided a clear description of the
study population included, and in three studies [37, 46,
47] no indications of referral to colonoscopy were
provided. In one study insufficient information was
provided [37] regarding the time period between index
test and the reference standard. In the remaining studies,
colonoscopy was performed after MR-colonography
within a time interval ranging from same day performance
[40, 41, 44–49] to a maximum of 4 weeks [42]. MR-
colonography findings were presented by segmental
unblinding in four studies [37, 42, 45, 49]. Of the
remaining studies one reported on a potential colono-
scopic reassessment in the case of inconsistencies
between MR-colonography and colonoscopy findings
[38], two studies did not describe any details of colonos-
copy (un)blinding methods [46, 48] and in six studies the
gastroenterologist was unaware of the MR findings during
the complete colonoscopy procedure. Uninterpretable
results of MR-colonography were reported in eight
studies [37–39, 42, 44–47]. In general, 11 studies fulfilled
at least eight methodological criteria.
Patient characteristics
Patient characteristics are outlined in Table 2. In this meta-
analysis we included 13 studies with in total 1,285 patients.
Five studies reported a study population of more than 100
patients [38, 42, 45, 47, 48] and these studies comprised
908 (71%) patients of the total study population. The
largest study population included 315 asymptomatic
individuals with a normal risk profile for CRC [42]. In
nine studies [38–41, 43–45, 48, 49] symptomatic and/or
asymptomatic patients at increased risk of CRC were
included, and in three studies [37, 46, 47] indications for
colonoscopy were unclear.
Imaging features and image analysis
MR imaging features are outlined in Tables 3 and 4. Most
of the studies reported all relevant data. However,there was
a variation in the preparation as well as the applied
technical parameters. Dark-lumen MR-colonography was
reported in nine studies [37, 39–45, 49] and a water-based
enema and intravenous paramagnetic contrast administra-
tion were used in eight of these studies (89%).
Individual reader experience was defined in four studies
ranging from 40 cases [38] to over 50 [48, 49]. In two other
studies [39, 40], reader experience was defined as more
316 Excluded Studies 
(based on title and/or abstract)
125    Duplicate studies 
  98    Study design  
  90    Non-related topic 
    3    < 10 patients included  
24 Excluded Studies 
  5  Human subjects did not undergo index and 
reference test [13-17] 
  10  Unable to construct 2 x 2 contingency tables [18-
 27] 
  2  Incomplete reference test [28, 29] 
  4  Reported data of the same study population 
 [30-33] 
  1  1.0 Tesla MRI [34] 
  2  Study design [35,36] 
37 full text articles
Scored for validity in consensus by 2 readers 
Cochrane search: 
6 titles 
EMBASE search: 
156 titles 
13 Included Studies 
PubMed search: 
191 titles 
Fig. 1 Flow chart indicating
selection of articles included for
analysis (and potentially rele-
vant studies that were excluded
by reviewers [13–36])
1034Table 1 Quality assessment of included studies using relevant items of the QUADAS tool
Study Representative
patient
population
Selection
criteria
specified
Accurate
verification
Time
interval
specified
a
Complete
sample size
verification
b
Reproducible
description
index test
Blinded
interpretation
index test
Blinded
interpretation
reference test
Intermediate
index test
results
reported
Description
of
withdrawals
Achiam
(2008)
[37]
Yes No Yes Unclear No Yes Yes No
c Yes Yes
Florie
(2007)
[38]
Yes Yes Yes Yes Yes Yes Yes Yes
d Yes Yes
Goehde
(2005)
[39]
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Hartmann
(2006)
[40]
Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Kerker
(2008)
[41]
Yes Yes Yes Yes No Yes Unclear Yes Unclear Yes
Kuehle
(2007)
[42]
Yes Yes Yes Yes No Yes Yes No
c Yes Yes
Lauenstein
(2002)
[43]
Yes Yes Yes Yes Yes Yes Yes Yes Unclear Unclear
Lauenstein
(2005)
[44]
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Leung
(2004)
[45]
Yes Yes Yes Yes Yes Yes Yes No
c Yes Yes
Luboldt
(1998)
[46]
Yes No Yes Yes Yes Yes Yes Unclear Yes Yes
Luboldt
(2000)
[47]
Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes
Saar
(2007)
[48]
Yes Yes Yes Yes Yes Yes Yes Unclear Unclear Yes
Saar
(2008)
[49]
Yes Yes Yes Yes Yes Yes Yes No
c Unclear Yes
aMaximum time interval was defined as 4 weeks
bDefined as at least 90% receiving the reference test
cSegmental unblinding
dReassessment in new session if needed
1035than 4 years [39]o r5 –15 years’ [40] clinical experience
with abdominal MRI; however, no proven competence was
shown for reading MR-colonography in these studies
(Table 5).
Data extraction
For each included study we were able to construct 2×2
contingency tables of the extracted determinates. However
Table 2 Study characteristics of included studies
Study Number of
subjects for
analysis
Consecutively
recruited
Indications
for
colonoscopy
a
Patients with
CRC or polyps
>10 mm
Prevalence of patients
with polyps >10 mm
(%)
Mean age
±SD; range
(years)
Sex ratio
(male/
female)
Study
design
Achiam
(2008)
[37]
47 Yes NA 12/47 25 NA NA Prospective
Florie
(2007)
[38]
200 Yes 5–8 12/200 6 58±12 128/72 Prospective
Goehde
(2005)
[39]
42 Yes 1–6 NA NA NA 18/24 Prospective
Hartmann
(2006)
[40]
92 Yes 1,2,3,9,10 17/92 18 61.5±14.5 52/40 Prospective
Kerker
(2008)
[41]
80 Unclear 1,3,4,10 NA NA NA NA Prospective
Kuehle
(2007)
[42]
315 NA 1 20/315 6.3 NA NA Prospective
Lauenstein
(2002)
[43]
24 NA 2,4,9 13/24 25 57.4; 33–78 12/12 Prospective
Lauenstein
(2005)
[44]
37 NA 2,4,5,9 NA NA NA NA Prospective
Leung
(2004)
[45]
156 NA 1,2,4,7,10 11/156 4.5 55.2±9.1 74/82 Prospective
Luboldt
(1998)
[46]
21 NA NA 4/21 19 NA NA Prospective
Luboldt
(2000)
[47]
117 NA NA 14/117 12 NA NA Prospective
Saar
(2007)
[48]
120 Yes 6,9 NA NA 69; 22–87 56/64 Prospective
Saar
(2008)
[49]
34 NA 2,4,6,7,9 NA NA 60
b;2 1 –88 21/13 Prospective
NA not available
a1 screening, 2 faecal blood, 3 abdominal complaints, 4 change in bowel habits, 5 personal history of CRC, 6 personal history of polyps, 7
family history of CRC, 8 family history of polyps, 9 faecal occult blood testing positive (FOBT+), 10 anaemia
bMedian age
1036no standard format of data presentation was found, as per
patient data were not reported for each threshold. In 11
studies [39–49] per patient reporting concerned at least
overall results, which included polyps of all sizes. In six
of these studies overall results were presented with at
least one additional threshold of per patient polyp data.
In two studies per patient data were presented as
sensitivity and specificity stratified to medium- and
large-sized polyps combined (6 mm or larger) and
polyps of 10 mm or larger; however, the overall polyp
data were missing [37, 38]. Corresponding authors were
contacted in order to obtain overall polyp data
(including those for polyps smaller than 6 mm), and
all supplied us with the required data. Per polyp data for
each of the different polyp size categories could be
obtained in 5 of the 13 studies (38%).
Table 3 MR imaging characteristics of included studies
Study Type of bowel preparation/
faecal tagging
Dietary
restrictions
Technical
method
Type of enema
used
Volume
(L)
Enema
pressure
Spasmolytic
drugs (mg)
Intravenous contrast
agent (mmol/kg)
Achiam
(2008)
[37]
4×200 cc ferumoxsil/
barium sulphate
Low-fibre
diet
Dark-
lumen
Water-based 2–2.5 1.5 m
H2O
Buscopan®
(40)
Dotarem® (0.2)
Florie
(2007) [38]
6×10 cc Magnevist® +
lactulose
Low-fibre
diet
Bright-
lumen
Mixture water/ga-
dolinium-based
1.9 0.8 m
H2O
Buscopan®
(20)
None
Goehde
(2005)
[39]
6×150 cc barium sulphate Low-fibre
diet
Dark-
lumen
Water-based 2–2.5 NA Buscopan®
(40)
Multihance® (0.2)
Hartmann
(2006)
[40]
Bowel cleansing (4 L PEG–
electr)
No Dark-
lumen
Water-based 2–2.5 NA Buscopan®
(40)
Multihance®
Kerker
(2008)
[41]
Bowel cleansing (4 L PEG
solution)
No Dark-
lumen
Water-based 2 NA Buscopan®
(40)
Magnevist®
Kuehle
(2007)
[42]
6 ×150 cc solution (5%
Gastrografin/1% bari-
um/0.2% bean gum)
No Dark-
lumen
Water-based 2 1–1.5 Buscopan®
(40)
Dotarem® (0.2)
Lauenstein
(2002)
[43]
4/5×200 cc barium sul-
phate
Low-fibre
diet
Dark-
lumen
Water-based 1.5–2.5 1.0–
1.5 m
H2O
Buscopan®
(20)
Multihance® (0.2)
Lauenstein
(2005)
[44]
Bowel cleansing (3 L
electrolyte solution)
No Dark-
lumen
Water-based 2.5 1.0 m
H2O
Buscopan®
(20)
Multihance® (0.2)
Leung
(2004)
[45]
Bowel cleansing
(phospho soda)
No Dark-
lumen
Air-based 30–40
puffs
a
NA Hyoscine
(20)
None
Luboldt
(1998)
[46]
Bowel cleansing (3 L
PEG solution)
No Bright-
lumen
Mixture water/ga-
dolinium-based
1.5–2.0 1–2m
H2O
Buscopan®
(20)
Magnevist® (0.1)
Luboldt
(2000)
[47]
Bowel cleansing (3 L bowel
preparation solution)
No Bright-
lumen
Mixture water/ga-
dolinium-based
1.8–3.0 1.0 m
H2O
Buscopan®
(20)
None
Saar (2007)
[48]
Bowel cleansing
(4–6 L PEG–electr)
No Bright-
lumen
Mixture water/ga-
dolinium-based
1.5–2.5 NA Buscopan®
(20)
None
Saar (2008)
[49]
Bowel cleansing (3–4L
electrolytic solution)
No Dark-
lumen
Water-based 2.5 ±1 m
H2O
Buscopan®
(40)
Multihance® (0.2)
PEG polyethylene glycol, electr electrolyte
aManual air-inflation
1037Table 4 MRI technical parameters of included studies
Study Type of MRI
scanner
Field
strength
(T)
Sequence TR (ms)/
TE(ms)
Matrix Slice
thickness
(mm)
FOV
(mm)
Prone (P)/
supine (S)
Imaging
plane
Breath
hold (s)
Examination
time (min)
Achiam
(2008) [37]
Philips 1.5 3D T1 3.2/1.6 NA 1.7 420 NA Coronal 22 NA
Florie (2007)
[38]
GE 1.5 3D T1 5.4/1.6 256×
192
2 480×
336
P/S Coronal 10–20 45
2D T2 1,354/64 320×
224
4 460×
322
P/S Axial
2D T2 1,050/62 256×
160
5 400×
280
P/S Coronal
Philips 1.5 3D T1 5.6/1.9 512×
304
2.5 480×
432
P/S Coronal 10–20 45
2D T2 676/165 256×
256
5 400×
320
P/S Axial
2D T2 867/195 256×
256
5 480×
432
P/S Coronal
Philips 3.0 3D T1 5.4/2.0 192×
163
2.5 480×
384
P/S Coronal 10–20 45
2D T2 1,002/60 455×
455
5 455×
455
P/S Axial
2D T2 1,002/60 304×
274
5 485×
485
P/S Coronal
Goehde
(2005) [39]
Siemens 1.5 3D T1 1.64/0.6 512×
460
1.5–2.0 450×
450
P Coronal 22 NA
Hartmann
(2006) [40]
Siemens 1.5 3D T1 3.1/1.17 NA 1.5–2.0 400×
400
P Coronal 22 NA
Kerker (2008)
[41]
Siemens 1.5 3DT1 1.92/0.8 NA NA 400 NA Coronal 20–25 NA
2DT1 522/22 NA NA 240 NA Sagittal
Kuehle
(2007) [42]
Siemens 1.5 3D T1 3.08/1.13 168×
256
1.8–2.4 500
(z)
P Coronal <20 NA
2DT1 125/1.83 168×
256
NA 500 P Axial
2D T1/
T2
a
3.79/1.9 205×
256
NA 400 P Coronal
Lauenstein
(2002) [43]
Siemens 1.5 3D T1 1.64/0.60 460×
512
1.57 450 P Coronal 22 <20
Lauenstein
(2005) [44]
Siemens 1.5 3D T1 3.1/1.1 180×
256
1.8
b 400 S Coronal 22 NA
2D T1/
T2
a
4.5/2.2 402×
512
3 400 P/S Coronal 21
Leung (2004)
[45]
Siemens 1.5 2D T2 ∞/56 256×
134
4 340–
400
P/S Coronal/
axial
24 20.6±2.7
3D T1 3.1/1.1 256×
165
2.5 380–
400
P/S Coronal 22
Luboldt
(1998) [46]
GE 1.5 3D T1 4.7/2 256×
160
2.2–3.6 380–
460
P/S NA 28 NA
1038Data analysis
Per patient analysis
Inter-study heterogeneity (I
2) for the detection of patients
with polyps, irrespective of size, was significant for
sensitivity (86%; 95% CI 79–91%) and proved moderate
for specificity (58%; 95% CI 28–76%). Therefore,
calculating summary estimates of sensitivity and specific-
ity for the detection of all polyps was not sensible in this
context (Fig. 2a). Outcomes for the detection of patients
with large polyps (10 mm or larger) were available in six
studies comprising 927 patients (72%). The I
2 percentage
for the sensitivities was 37% (95% CI 10–63%) and for the
specificities 60% (95% CI 17–80%). The per patient
summary estimates of sensitivity and specificity values for
this polyp size threshold were 88% (95% CI 63–97%) and
99% (95% CI 95–100%), respectively (Fig. 2b). Because
of this low to moderate heterogeneity, per patient data for
polyps of 10 mm or larger were analysed with the use of a
random effects approach.
Per polyp analysis
For per polyp data, using the I
2 test statistics we found
significant heterogeneity for polyps smaller than 6 mm
(81% (95% CI 65–90%) and polyps 6–9 mm (80% (95%
CI 62–89%), which impedes reasonable meta-analysis for
these two thresholds. Individual sensitivities for polyps
smaller than 6 mm are presented in Fig. 3a. Individual
per polyp sensitivities for polyps 6–9 mm were based on
the data of six studies comprising 204 polyps (Fig. 3b).
The I
2 for the sensitivity of polyps 10 mm or larger was
51% (95% CI 8–74%). For polyps 10 mm or larger the
mean sensitivity estimate was 84% (95% CI 66–94%)
(Fig. 3c) and was based on the results of 145 polyps of
10 mm or larger and obtained by the random effects
approach. Reported individual detection rates of MR-
colonography for CRC were 100% comprising 32
carcinomas in 5 studies (Fig. 4). In two studies an
additional subanalysis for adenomas was performed [40,
42]. Per patient sensitivity for detecting adenomatous
polyps 10 mm or larger in these studies was 100% and
87%, respectively.
Discussion
Our systematic review demonstrates an average per patient
sensitivity of 88% (95% CI 63–97%) and specificity of
99% (95% CI 95–100%) for the detection of large polyps
(10 mm or larger) with the use of MR-colonography. The
sensitivity of MR-colonography in detecting CRC was
100%. At per polyp analysis, a summary sensitivity
estimate of MR-colonography in detecting polyps 10 mm
or larger was acceptable (84%; 95% CI 66–94%).
Additionally, substantial variation is shown in data
reporting between studies, as no standard format is used
for presenting both per patient and per polyp results.
Study Type of MRI
scanner
Field
strength
(T)
Sequence TR (ms)/
TE(ms)
Matrix Slice
thickness
(mm)
FOV
(mm)
Prone (P)/
supine (S)
Imaging
plane
Breath
hold (s)
Examination
time (min)
2D T1 6/1.3 256×
160
10 360–
400
NA NA 28
Luboldt
(2000) [47]
GE 1.5 3D T1 3.8/2.5 384×
192
2–3 340–
420
P/S Coronal <30 NA
2D T2 ∞/65 256×
160
6 340–
420
P/S Coronal <30
Saar (2007)
[48]
Philips 1.5 2D T1 4/1.7 128×
128
150 450×
450
P/S Coronal 20–23 21.5
3D T1 3.3/1.3 256×
256
1.5 450×
450
P/S Coronal 20–23
Saar (2008)
[49]
Siemens 3.0 3D T1 2.53/1.03 384×
384
1.6×1.0×
1.5
c
400×
400
S Coronal NA NA
3D T1 3.14/1.51 256×
256
2.4×1.x1.5
c 400×
400
S Coronal
NA not available
aBalanced gradient echo (GRE)
bUsing zero-filling interpolation
cVoxel size
Table 4 (continued)
1039Important variability between study results wasshown in
sensitivity and specificity values, which is reflected by the
significantly high I
2 values (above 75%) for overall per
patient data and per polyp data in the detection of polyps
smaller than 6 mm and polyps 6–9 mm, and impeded the
complementary performance of a rational meta-analysis.
This heterogeneity might be a consequence of a prominent
diversity in technical aspects, as no consensus has been
achieved regarding important study elements. This appears
to be the opposite of CT-colonography, for which—
because of the rapid development of this technique—a
consensus statement is currently established [50, 51].
Halligan et al. [52] proposed a minimum data set for study-
level reporting for CT-colonography in order to improve
the quality of reporting in this field. The most obvious
measure is to adopt similar reporting of study character-
istics to those of CT-colonography as far as possible. Still,
compared with CT-colonography, research on MR-colono-
graphy is rather limited and more importantly to date no
consensus has been achieved regarding imaging aspects.
Therefore similar recommendations to those applied in CT-
colonography can only be achieved for certain aspects of
MR-colonography.
In a substantial number of included studies, im-
portant demographic characteristics could often not be
derived from the available dataset after withdrawals
were excluded from the initial included population.
Regarding the description of the presence of risk
factors for CRC in the study cohort, reports were
detailed. Most primary studies included patients at
increased risk of colorectal polyps, which leads to a
higher prevalence of abnormalities and will ultimately
result in better diagnostic outcomes [53]. One study
exclusively reports on a screening population consisting
of 315 individuals at no increased risk of CRC, and the
overall prevalence of clinically relevant abnormalities
in this cohort was 6.3% [42]. It should be stated that a
detailed description regarding demographic character-
istics and potential risk factors for CRC is required for
study reporting. Moreover complete description of the
data collection (prospective, retrospective) and partici-
pant sampling (consecutively) should be provided [54].
Similar to CT-colonography, the prerequisite for MR-
colonography is a clean, well-distended colon with few
residual faeces. Although the reported methods of achiev-
ing this baseline varied considerably, the technical
specifications of the materials and methods used to perform
MR-colonography were sufficiently described in all
studies. Because of the small groups and heterogeneous
data, we were not able to perform a formal subgroup
analysis and therefore we are unable to propose recom-
mendations regarding the application of specific MR-
colonography techniques (i.e. dark lumen, bright lumen,
bowel purgation, faecal tagging).
Six studies (46%) reported adequate determinates in
order to calculate per patient sensitivity and specificity
values for separate size thresholds. In two of these studies
calculation could be performed for each of three different
Table 5 Image analysis characteristics
Study Number of
observers
Experience of
observers defined
b
Data analysis
method
c
Consensus
reading
Review time (min) Image quality
assessment
e
Achiam (2008) [37] 2 50 cases 2D No
d NA Yes
Florie (2007) [38] 2 40 cases 2D No
d NA Yes
Goehde (2005) [39] 2 No 2D Yes NA Yes
Hartmann (2006) [40]5
a No 2D/3D Yes NA No
Kerker (2008) [41] 2 No NA NA NA No
Kuehle (2007) [42] 2 No 2D/3D Yes NA Yes
Lauenstein (2002) [43] 2 No 2D/3D Yes NA Yes
Lauenstein (2005) [44] 2 No 2D/3D Yes NA Yes
Leung (2004) [45] 2 No 2D/3D Yes NA No
Luboldt (1998) [46] 2 No 2D/3D Yes 35–55 Yes
Luboldt (2000) [47] 2 No 2D/3D Yes NA Yes
Saar (2007) [48] 2 >50 cases 2D/3D Yes 23.5 (13.5–48) Yes
Saar (2008) [49] 2 >50 cases 2D Yes NA Yes
NA not available
a2 radiologists and 3 gastroenterologists
bDefined as exact number of validated MR-colonography training cases
c2D multiplanar reformation (MPR), 3D virtual endoscopy
dQuality assessment includes assessment of colonic distension, artefacts, lumen homogeneity or SNR/CNR
eInterobserver agreement
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Fig. 2 a Forest plot of per
patient sensitivity and specifici-
ty, including sensitivity and
specificity estimates, for all
polyps. FN false-negative, FP
false-positive, TN true-negative,
TP true-positive values.
Lauenstein (2005) compared
two different sequences in the
same study population [44]; re-
sults of both sequences are used
for calculating sensitivity and
specificity estimates. Heteroge-
neity (I
2) between study results
for sensitivities was 86%
(CI 79–91%) and for specifici-
ties 58% (CI 28–76%). b Forest
plot of per patient sensitivity
and specificity, including pooled
sensitivity and specificity, for
polyps 10 mm or larger.
Heterogeneity (I
2) between
study results for sensitivities
was 37% (CI 10–63%) and for
specificities 60% (CI 17–80%)
1041size thresholds with additional split analyses for adenomas.
Although per patient analysis on overall polyp data were
included in our statistical approach, we believe that similar
to CT-colonography a reasonable minimum size for
reported polyps is larger than 5 mm [51]. Therefore we
recommend that per patient analysis must be reported both
stratified into thresholds of medium and large polyps (6–
9 mm and 10 mm or larger, respectively) and combined.
Additionally we propose per polyp sensitivity results for
polyps 6–9mm andpolyps 10 mmor larger, asthis analysis
enlightens the effective diagnostic performance of the test
[55].
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b
a Fig. 3 Forest plot of per polyp
sensitivity, including pooled per
polyp sensitivity, for polyps
smaller than 6 mm (a), polyps
6–9m m( b) and polyps 10 mm
or larger (c). FP false-positive,
TN true-negative values. Het-
erogeneity (I
2) among study re-
sults for sensitivities for polyps
smaller than 6 mm was 81% (CI
65–90%); polyps 6–9 mm, 80%
(CI 62–89%); and polyps
10 mm or larger, 51% (CI 8–
74%)
1042In CT-colonography, diagnostic performance is known
to be closely related to the level of observers’ experience
[56]. In our systematic review, most of the included studies
insufficiently defined observer experience. Until now the
required level of experience was not known for either MR-
colonography or CT-colonography, but in CT-colonogra-
phy 50 verified training cases has been specified to be an
absolute minimum [57]. MR-colonography is most likely
to be more difficult to interpret than CT-colonography;
therefore observer experience of just 40–50 validated MR-
colonography cases, which was reported in several studies,
is always expected to be inadequate. As observer
performance plays a substantial role in the measurement
of accuracy, we recommend clearly describing the total
number of per study observers together with a clear
definition of the observers’ experience, quantified as the
total number of verified cases interpreted.
To our knowledge, so far one meta-analysis has been
carried out to evaluate the diagnostic performance of MR-
colonography [8]. In that meta-analysis sensitivity and
specificity estimates for the detection of polyps of all sizes
combined were 75% and 96%, but the presence of
significant heterogeneity between the different studies
minimised the statistical value of these outcomes. Indivi-
dual study sensitivities in our analysis differed markedly as
well and hampered quantification of all extracted data.
However to be confronted with statistical heterogeneity is
almost unavoidable when performing a meta-analysis of
diagnostic studies.
Despite the statistical heterogeneity, the clinical rele-
vance of summarising the sensitivity estimate for the
detection of polyps of all sizes, as calculated in the previous
meta-analysis, is limited, and reporting per relevant size
category is far more informative. Importantly, in the
present study we were able to perform additional analysis
for the clinically most relevant polyp size threshold on both
a per patient and a per polyp basis. This was based on a
considerable albeit not large number of polyps 10 mm or
larger (145 polyps in total).
Furthermore, the previous meta-analysis included
eight earlier comparative studies (1998–2004) with
similar inclusion criteria to those we have set in our
study. However in three of these eight included studies
[18, 21, 25], we were not able to extract important
determinates (e.g. FP, TNs) and these were consequently
excluded from our analysis. As no false-positive
findings of any size were extracted for the primary
studies concerned, the authors of the previous meta-
analysis reported an excellent overall pooled specificity.
In total we included three studies that were also
evaluated in the previous meta-analysis [43, 45, 47],
as we additionally excluded one study based on the use
of 1.0-T field strength [34] and one study based on the
inclusion of fewer than 10 patients [58].
A limitation of our study was the exclusion of seven
studies due to the absence of per patient polyp data and
consequently not meeting our inclusion criteria. This could
potentially result in a selection bias andultimately in biased
diagnostic estimates. Therefore wewould like to emphasise
the importance of completeness in data reporting in
comparative MR-colonography studies as this will facil-
itate future meta-analyses.
In our study publication bias is inevitable, regardless of
attempts to use appropriate analytical approaches and
execute a wide search without essential restrictions.
However, we did not evaluate publication bias because
much controversy remains about the applied statistical
methods and outcomes in studies detecting publication bias
[59].
In recent meta-analyses [52, 55, 60], high sensitivity
estimates (ranging from 85 to 93%) were reported for
detecting patients with large polyps by using CT-
colonography. Our results seem comparable as the applied
inclusion criteria do not differ considerably, and therefore
MR-colonography might be regarded as a future compe-
titive diagnostic tool for this category of colorectal polyps.
In this context the principal advantage of MR-colonogra-
phy is the use of non-ionising radiation. However one must
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Lauenstein 2002(10/10)
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Fig. 4 Forest plot of sensitivity
of MR-colonography in the
detection of CRC. Lauenstein
(2005) and Saar (2008) com-
pared two different sequences in
the same study population [44,
49]; results of both sequences
are outlined in this forest plot
1043bear in mind that currently MR-colonography is hampered
by its limited availability, unfavourable cost-effectiveness
and longer examination time.
Moreover, in order to compare the accuracy of these two
techniques, ideally it would be preferable to execute a
direct head-to-head comparison study. To date one study
compared CT-colonography with MR-colonography in the
detection of colorectal abnormalities in the same study
population [19]. However CT-colonography was not
performed using state-of-the-art CT-colonography, which
makes it difficult to pose meaningful conclusions.
In conclusion, this systematic review shows that MR-
colonography can play a role in the detection of large
colorectal polyps in patients at increased risk of CRC. More
research is needed to define its role in the detection of
medium-sized polyps in this population, as this is far from
established to date. Sizeable prospective screening studies
using state-of-the-art technique are warranted for this
purpose. During our analysis we found little uniformity in
the methods used with regard to MR-colonography and data
reporting. Ultimately, this leads to considerable heterogene-
ity, and therefore we propose reporting recommendations
regarding crucial study design characteristics (i.e. definition
of observer experience in MR-colonography, standardised
perpatientandperpolypdatapresentation)forfuturestudies.
The methodology as used in CT-colonography studies can
serve as a framework for new MR-colonography studies.
Appendix
Details of the computer-assisted literature search are
summarised in Table 6.
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Table 6 Characteristics of the search strategy
Search terms Number of hits
PUBMED
#1 MR-colonography [keyword] 122
#2 Magnetic resonance colonography [keyword] 175
#3 Virtual colonoscopy [keyword] 1,230
#4 Magnetic resonance imaging [MeSH} 225,890
#5 #3 AND #4 115
#6 #1 OR #2 OR #5 209
Limits
Human and publication date: from 1997 to 2009 191
EMBASE
#1 MR-colonography [keyword] 99
#2 Magnetic resonance colonography [keyword] 78
#3 Exp Nuclear Magnetic Resonance Imaging [MeSH] 232,502
#4 Virtual colonoscopy [keyword] 365
#5 #3 AND #4 51
#6 #1 OR #2 OR #5 175
Limits 156
Human and publication date: from 1997 to 2009
Cochrane
#1 MR-colonography [Title, Abstract, Keyword] 3
#2 Magnetic resonance colonography [Title, Abstract, Keyword] 6
#3 Magnetic resonance imaging [Title, Abstract, Keyword] 4,008
#4 Virtual colonoscopy [Title, Abstract, Keyword] 32
#5 #3 AND #4 1
#6 #1 OR #2 OR #5 6
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